X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3876) 3876
Book Chapter (89) 89
Dissertation (32) 32
Conference Proceeding (17) 17
Publication (15) 15
Magazine Article (2) 2
Book / eBook (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
α-synuclein (3571) 3571
alpha-synuclein (2710) 2710
parkinson's disease (2062) 2062
humans (2015) 2015
neurosciences (1694) 1694
animals (1298) 1298
parkinsons-disease (1267) 1267
alpha-synuclein - metabolism (1251) 1251
parkinson’s disease (910) 910
biochemistry & molecular biology (828) 828
lewy bodies (783) 783
male (730) 730
neurodegeneration (726) 726
alzheimers-disease (656) 656
alpha-synuclein - genetics (632) 632
neurodegenerative diseases (624) 624
parkinson disease - metabolism (612) 612
mice (608) 608
clinical neurology (603) 603
aggregation (552) 552
pathology (544) 544
synuclein (543) 543
female (534) 534
proteins (526) 526
α‐synuclein (525) 525
mutation (518) 518
oxidative stress (503) 503
dementia (460) 460
parkinson disease - pathology (455) 455
aged (454) 454
nervous system (443) 443
nervous system diseases (430) 430
brain (421) 421
neurology (421) 421
dopamine (402) 402
parkinson disease - genetics (391) 391
movement disorders (377) 377
neurons (377) 377
multiple system atrophy (376) 376
alpha-synuclein - chemistry (374) 374
neurons - metabolism (367) 367
brain - metabolism (360) 360
middle aged (359) 359
synucleins (355) 355
cell biology (347) 347
protein (346) 346
rats (327) 327
brain - pathology (310) 310
alzheimer's disease (304) 304
in-vitro (294) 294
disease models, animal (290) 290
phosphorylation (283) 283
tau (280) 280
substantia-nigra (279) 279
autophagy (277) 277
aged, 80 and over (272) 272
pathogenesis (269) 269
immunohistochemistry (266) 266
nerve tissue proteins - metabolism (263) 263
expression (255) 255
biophysics (246) 246
parkinson disease (245) 245
lewy body (240) 240
neurons - pathology (239) 239
parkinsons disease (239) 239
disease (236) 236
mice, inbred c57bl (235) 235
mice, transgenic (208) 208
apoptosis (201) 201
amyloid (195) 195
neurotoxicity (195) 195
oligomers (192) 192
analysis (189) 189
dopamine - metabolism (189) 189
protein aggregation (187) 187
cell line, tumor (185) 185
lewy bodies - pathology (181) 181
toxicity (180) 180
lewy bodies - metabolism (178) 178
dementia with lewy bodies (177) 177
nerve tissue proteins - genetics (176) 176
animal diseases (170) 170
pharmacology & pharmacy (170) 170
cells, cultured (169) 169
mouse model (169) 169
biomedicine (168) 168
parkinson disease - physiopathology (168) 168
dopaminergic-neurons (167) 167
substantia nigra (166) 166
transgenic mice (166) 166
binding (164) 164
lewy body disease (164) 164
protein binding (161) 161
protein folding (161) 161
mitochondria (159) 159
mental disorders (154) 154
parkin (154) 154
review (153) 153
adult (151) 151
lewy body disease - pathology (151) 151
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3902) 3902
Chinese (72) 72
Japanese (44) 44
French (12) 12
German (11) 11
Korean (11) 11
Polish (4) 4
Spanish (3) 3
Hungarian (2) 2
Portuguese (2) 2
Russian (2) 2
Czech (1) 1
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FEBS letters, ISSN 0014-5793, 2011, Volume 585, Issue 3, pp. 561 - 566
Journal Article
Journal Article
Movement Disorders, ISSN 0885-3185, 08/2017, Volume 32, Issue 8, pp. 1117 - 1130
Journal Article
Movement disorders, ISSN 1531-8257, 2019, Volume 34, Issue 8, pp. 1154 - 1163
Background Pathological and genetic evidence implicates toxic effects of aggregated α‐synuclein in the pathophysiology of neuronal dysfunction and degeneration... 
synucleinopathy | pharmacokinetics | phase I | Parkinson's disease | α‐synuclein | α-synuclein | DIAGNOSIS | SCALE | alpha-synuclein | CLINICAL NEUROLOGY | PARKINSONS-DISEASE | EKG | Neuroimaging | Neurodegenerative diseases | Parkinsons disease | Clinical trials | Cerebrospinal fluid | Synuclein | Immunotherapy | Monoclonal antibodies | Degeneration | Pharmacokinetics | Movement disorders
Journal Article